Predicting response to bevacizumab in ovarian cancer: a panel of potential biomarkers informing treatment selection

PURPOSE: The aim of this study was to identify and validate novel predictive and/or prognostic serum proteomic biomarkers in patients with epithelial ovarian cancer (EOC) treated as part of the phase III international ICON7 clinical trial. EXPERIMENTAL DESIGN: ICON7 was a phase III international tri...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Collinson, Fiona, Hutchinson, Michelle, Craven, Rachel A., Cairns, David A., Zougman, Alexandre, Wind, Tobias C., Gahir, Narinder, Messenger, Michael P., Jackson, Sharon, Thompson, Douglas, Adusei, Cybil, Ledermann, Jonathan, Hall, Geoffrey, Jayson, Gordon C., Selby, Peter J., Banks, Rosamonde E.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3780518/
https://ncbi.nlm.nih.gov/pubmed/23935036
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-13-0489
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados